▶ 調査レポート

肺動脈高血圧症治療の世界市場2018

• 英文タイトル:Global Pulmonary Arterial Hypertension Treatment Sales Market Report 2018

QYResearchが調査・発行した産業分析レポートです。肺動脈高血圧症治療の世界市場2018 / Global Pulmonary Arterial Hypertension Treatment Sales Market Report 2018 / D110809資料のイメージです。• レポートコード:D110809
• 出版社/出版日:QYResearch / 2018年10月
• レポート形態:英文、PDF、106ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:製薬・医療
• 販売価格(消費税別)
  Single User License¥444,000 (USD4,000)▷ お問い合わせ
  Enterprise License¥888,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、肺動脈高血圧症治療の世界市場について調査・分析し、肺動脈高血圧症治療のメーカー別販売量、市場シェア分析、種類別販売分析(血管拡張剤、ホスホジエステラーゼ5(PDE5)阻害剤、エンドセリン受容体アンタゴニスト(ERA)、可溶性グアニル酸シクラーゼ(SGC)刺激剤)、用途別販売分析(病院薬局、小売薬局、オンライン薬局)、地域別販売分析(米国、中国、欧州、日本、東南アジア、インド)、価格動向、企業動向、肺動脈高血圧症治療産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・肺動脈高血圧症治療市場概要
・肺動脈高血圧症治療のメーカー別販売量・メーカー別シェア
・肺動脈高血圧症治療の世界市場:種類別販売量(血管拡張剤、ホスホジエステラーゼ5(PDE5)阻害剤、エンドセリン受容体アンタゴニスト(ERA)、可溶性グアニル酸シクラーゼ(SGC)刺激剤)
・肺動脈高血圧症治療の世界市場:用途別販売量(病院薬局、小売薬局、オンライン薬局)
・肺動脈高血圧症治療の世界市場:地域別販売量・市場シェア
・肺動脈高血圧症治療の米国市場規模
・肺動脈高血圧症治療の中国市場規模
・肺動脈高血圧症治療の欧州市場規模
・肺動脈高血圧症治療の日本市場規模
・肺動脈高血圧症治療の東南アジア市場規模
・肺動脈高血圧症治療のインド市場規模
・肺動脈高血圧症治療のメーカー別分析(企業概要、事業概要、製品概要、収益、価格等)
・肺動脈高血圧症治療のコスト分析・価格動向
・肺動脈高血圧症治療の産業チェーン(サプライチェーン分析)
・肺動脈高血圧症治療のマーケティング戦略・販売チャネル、流通業者
・肺動脈高血圧症治療市場への影響要因分析
・肺動脈高血圧症治療の世界市場予測
・肺動脈高血圧症治療の米国市場予測
・肺動脈高血圧症治療の中国市場予測
・肺動脈高血圧症治療の欧州市場予測
・肺動脈高血圧症治療の日本市場予測
・肺動脈高血圧症治療の東南アジア市場予測
・肺動脈高血圧症治療のインド市場予測
・肺動脈高血圧症治療の種類別世界市場予測(血管拡張剤、ホスホジエステラーゼ5(PDE5)阻害剤、エンドセリン受容体アンタゴニスト(ERA)、可溶性グアニル酸シクラーゼ(SGC)刺激剤)
・肺動脈高血圧症治療の用途別世界市場予測(病院薬局、小売薬局、オンライン薬局)
...

This report studies the global Pulmonary Arterial Hypertension Treatment market status and forecast, categorizes the global Pulmonary Arterial Hypertension Treatment market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
Pulmonary arterial hypertension- commonly known as PAH- is characterized by increased pressure in the pulmonary arteries due to structural changes in blood vessel walls, aggregation of platelets and alteration of smooth muscle cell function- eventually elevating pressure in the pulmonary arteries responsible for pumping blood to the lungs. This eventually leads to right heart failure and, ultimately, death.
The global Pulmonary Arterial Hypertension Treatment market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major players covered in this report
GlaxoSmithKline plc
Eli Lilly and Company
Pfizer Inc.Actelion Inc
United Therapeutic Corporation
SteadyMed Ltd
Gilead Sciences, Inc
Teva Pharmaceuticals Inc
Bayer AG

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Vasodilators
Phosphodiesterase 5 (PDE 5) Inhibitors
Endothelin Receptor Antagonists (ERA)
Soluble Guanylate Cyclase (SGC) Stimulator
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

The study objectives of this report are:
To analyze and study the global Pulmonary Arterial Hypertension Treatment sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Pulmonary Arterial Hypertension Treatment players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Pulmonary Arterial Hypertension Treatment are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Pulmonary Arterial Hypertension Treatment Manufacturers
Pulmonary Arterial Hypertension Treatment Distributors/Traders/Wholesalers
Pulmonary Arterial Hypertension Treatment Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company’s specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Pulmonary Arterial Hypertension Treatment market, by end-use.
Detailed analysis and profiles of additional market players.

レポート目次

Table of Contents

Global Pulmonary Arterial Hypertension Treatment Sales Market Report 2018
1 Pulmonary Arterial Hypertension Treatment Market Overview
1.1 Product Overview and Scope of Pulmonary Arterial Hypertension Treatment
1.2 Classification of Pulmonary Arterial Hypertension Treatment by Product Category
1.2.1 Global Pulmonary Arterial Hypertension Treatment Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Pulmonary Arterial Hypertension Treatment Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Vasodilators
1.2.4 Phosphodiesterase 5 (PDE 5) Inhibitors
1.2.5 Endothelin Receptor Antagonists (ERA)
1.2.6 Soluble Guanylate Cyclase (SGC) Stimulator
1.3 Global Pulmonary Arterial Hypertension Treatment Market by Application/End Users
1.3.1 Global Pulmonary Arterial Hypertension Treatment Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.1 Hospital Pharmacies
1.3.2 Retail Pharmacies
1.3.3 Online Pharmacies
1.4 Global Pulmonary Arterial Hypertension Treatment Market by Region
1.4.1 Global Pulmonary Arterial Hypertension Treatment Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Pulmonary Arterial Hypertension Treatment Status and Prospect (2013-2025)
1.4.3 Europe Pulmonary Arterial Hypertension Treatment Status and Prospect (2013-2025)
1.4.4 China Pulmonary Arterial Hypertension Treatment Status and Prospect (2013-2025)
1.4.5 Japan Pulmonary Arterial Hypertension Treatment Status and Prospect (2013-2025)
1.4.6 Southeast Asia Pulmonary Arterial Hypertension Treatment Status and Prospect (2013-2025)
1.4.7 India Pulmonary Arterial Hypertension Treatment Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Pulmonary Arterial Hypertension Treatment (2013-2025)
1.5.1 Global Pulmonary Arterial Hypertension Treatment Sales and Growth Rate (2013-2025)
1.5.2 Global Pulmonary Arterial Hypertension Treatment Revenue and Growth Rate (2013-2025)

2 Global Pulmonary Arterial Hypertension Treatment Competition by Players/Suppliers, Type and Application
2.1 Global Pulmonary Arterial Hypertension Treatment Market Competition by Players/Suppliers
2.1.1 Global Pulmonary Arterial Hypertension Treatment Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Pulmonary Arterial Hypertension Treatment Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Pulmonary Arterial Hypertension Treatment (Volume and Value) by Type
2.2.1 Global Pulmonary Arterial Hypertension Treatment Sales and Market Share by Type (2013-2018)
2.2.2 Global Pulmonary Arterial Hypertension Treatment Revenue and Market Share by Type (2013-2018)
2.3 Global Pulmonary Arterial Hypertension Treatment (Volume and Value) by Region
2.3.1 Global Pulmonary Arterial Hypertension Treatment Sales and Market Share by Region (2013-2018)
2.3.2 Global Pulmonary Arterial Hypertension Treatment Revenue and Market Share by Region (2013-2018)
2.4 Global Pulmonary Arterial Hypertension Treatment (Volume) by Application

3 United States Pulmonary Arterial Hypertension Treatment (Volume, Value and Sales Price)
3.1 United States Pulmonary Arterial Hypertension Treatment Sales and Value (2013-2018)
3.1.1 United States Pulmonary Arterial Hypertension Treatment Sales and Growth Rate (2013-2018)
3.1.2 United States Pulmonary Arterial Hypertension Treatment Revenue and Growth Rate (2013-2018)
3.1.3 United States Pulmonary Arterial Hypertension Treatment Sales Price Trend (2013-2018)
3.2 United States Pulmonary Arterial Hypertension Treatment Sales Volume and Market Share by Players (2013-2018)
3.3 United States Pulmonary Arterial Hypertension Treatment Sales Volume and Market Share by Type (2013-2018)
3.4 United States Pulmonary Arterial Hypertension Treatment Sales Volume and Market Share by Application (2013-2018)

4 Europe Pulmonary Arterial Hypertension Treatment (Volume, Value and Sales Price)
4.1 Europe Pulmonary Arterial Hypertension Treatment Sales and Value (2013-2018)
4.1.1 Europe Pulmonary Arterial Hypertension Treatment Sales and Growth Rate (2013-2018)
4.1.2 Europe Pulmonary Arterial Hypertension Treatment Revenue and Growth Rate (2013-2018)
4.1.3 Europe Pulmonary Arterial Hypertension Treatment Sales Price Trend (2013-2018)
4.2 Europe Pulmonary Arterial Hypertension Treatment Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Pulmonary Arterial Hypertension Treatment Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Pulmonary Arterial Hypertension Treatment Sales Volume and Market Share by Application (2013-2018)

5 China Pulmonary Arterial Hypertension Treatment (Volume, Value and Sales Price)
5.1 China Pulmonary Arterial Hypertension Treatment Sales and Value (2013-2018)
5.1.1 China Pulmonary Arterial Hypertension Treatment Sales and Growth Rate (2013-2018)
5.1.2 China Pulmonary Arterial Hypertension Treatment Revenue and Growth Rate (2013-2018)
5.1.3 China Pulmonary Arterial Hypertension Treatment Sales Price Trend (2013-2018)
5.2 China Pulmonary Arterial Hypertension Treatment Sales Volume and Market Share by Players (2013-2018)
5.3 China Pulmonary Arterial Hypertension Treatment Sales Volume and Market Share by Type (2013-2018)
5.4 China Pulmonary Arterial Hypertension Treatment Sales Volume and Market Share by Application (2013-2018)

6 Japan Pulmonary Arterial Hypertension Treatment (Volume, Value and Sales Price)
6.1 Japan Pulmonary Arterial Hypertension Treatment Sales and Value (2013-2018)
6.1.1 Japan Pulmonary Arterial Hypertension Treatment Sales and Growth Rate (2013-2018)
6.1.2 Japan Pulmonary Arterial Hypertension Treatment Revenue and Growth Rate (2013-2018)
6.1.3 Japan Pulmonary Arterial Hypertension Treatment Sales Price Trend (2013-2018)
6.2 Japan Pulmonary Arterial Hypertension Treatment Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Pulmonary Arterial Hypertension Treatment Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Pulmonary Arterial Hypertension Treatment Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Pulmonary Arterial Hypertension Treatment (Volume, Value and Sales Price)
7.1 Southeast Asia Pulmonary Arterial Hypertension Treatment Sales and Value (2013-2018)
7.1.1 Southeast Asia Pulmonary Arterial Hypertension Treatment Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Pulmonary Arterial Hypertension Treatment Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Pulmonary Arterial Hypertension Treatment Sales Price Trend (2013-2018)
7.2 Southeast Asia Pulmonary Arterial Hypertension Treatment Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Pulmonary Arterial Hypertension Treatment Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Pulmonary Arterial Hypertension Treatment Sales Volume and Market Share by Application (2013-2018)

8 India Pulmonary Arterial Hypertension Treatment (Volume, Value and Sales Price)
8.1 India Pulmonary Arterial Hypertension Treatment Sales and Value (2013-2018)
8.1.1 India Pulmonary Arterial Hypertension Treatment Sales and Growth Rate (2013-2018)
8.1.2 India Pulmonary Arterial Hypertension Treatment Revenue and Growth Rate (2013-2018)
8.1.3 India Pulmonary Arterial Hypertension Treatment Sales Price Trend (2013-2018)
8.2 India Pulmonary Arterial Hypertension Treatment Sales Volume and Market Share by Players (2013-2018)
8.3 India Pulmonary Arterial Hypertension Treatment Sales Volume and Market Share by Type (2013-2018)
8.4 India Pulmonary Arterial Hypertension Treatment Sales Volume and Market Share by Application (2013-2018)

9 Global Pulmonary Arterial Hypertension Treatment Players/Suppliers Profiles and Sales Data
9.1 GlaxoSmithKline plc
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Pulmonary Arterial Hypertension Treatment Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 GlaxoSmithKline plc Pulmonary Arterial Hypertension Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 Eli Lilly and Company
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Pulmonary Arterial Hypertension Treatment Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Eli Lilly and Company Pulmonary Arterial Hypertension Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 Pfizer Inc.Actelion Inc
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Pulmonary Arterial Hypertension Treatment Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Pfizer Inc.Actelion Inc Pulmonary Arterial Hypertension Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 United Therapeutic Corporation
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Pulmonary Arterial Hypertension Treatment Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 United Therapeutic Corporation Pulmonary Arterial Hypertension Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 SteadyMed Ltd
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Pulmonary Arterial Hypertension Treatment Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 SteadyMed Ltd Pulmonary Arterial Hypertension Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 Gilead Sciences, Inc
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Pulmonary Arterial Hypertension Treatment Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Gilead Sciences, Inc Pulmonary Arterial Hypertension Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview
9.7 Teva Pharmaceuticals Inc
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Pulmonary Arterial Hypertension Treatment Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Teva Pharmaceuticals Inc Pulmonary Arterial Hypertension Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
9.7.4 Main Business/Business Overview
9.8 Bayer AG
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Pulmonary Arterial Hypertension Treatment Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Bayer AG Pulmonary Arterial Hypertension Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
9.8.4 Main Business/Business Overview

10 Pulmonary Arterial Hypertension Treatment Maufacturing Cost Analysis
10.1 Pulmonary Arterial Hypertension Treatment Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Pulmonary Arterial Hypertension Treatment
10.3 Manufacturing Process Analysis of Pulmonary Arterial Hypertension Treatment

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Pulmonary Arterial Hypertension Treatment Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Pulmonary Arterial Hypertension Treatment Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Pulmonary Arterial Hypertension Treatment Market Forecast (2018-2025)
14.1 Global Pulmonary Arterial Hypertension Treatment Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Pulmonary Arterial Hypertension Treatment Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Pulmonary Arterial Hypertension Treatment Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Pulmonary Arterial Hypertension Treatment Price and Trend Forecast (2018-2025)
14.2 Global Pulmonary Arterial Hypertension Treatment Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Pulmonary Arterial Hypertension Treatment Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Pulmonary Arterial Hypertension Treatment Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Pulmonary Arterial Hypertension Treatment Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Pulmonary Arterial Hypertension Treatment Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Pulmonary Arterial Hypertension Treatment Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Pulmonary Arterial Hypertension Treatment Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Pulmonary Arterial Hypertension Treatment Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Pulmonary Arterial Hypertension Treatment Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Pulmonary Arterial Hypertension Treatment Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Pulmonary Arterial Hypertension Treatment Sales Forecast by Type (2018-2025)
14.3.2 Global Pulmonary Arterial Hypertension Treatment Revenue Forecast by Type (2018-2025)
14.3.3 Global Pulmonary Arterial Hypertension Treatment Price Forecast by Type (2018-2025)
14.4 Global Pulmonary Arterial Hypertension Treatment Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Pulmonary Arterial Hypertension Treatment
Figure Global Pulmonary Arterial Hypertension Treatment Sales Volume Comparison (K Units) by Type (2013-2025)
Figure Global Pulmonary Arterial Hypertension Treatment Sales Volume Market Share by Type (Product Category) in 2017
Figure Vasodilators Product Picture
Figure Phosphodiesterase 5 (PDE 5) Inhibitors Product Picture
Figure Endothelin Receptor Antagonists (ERA) Product Picture
Figure Soluble Guanylate Cyclase (SGC) Stimulator Product Picture
Figure Global Pulmonary Arterial Hypertension Treatment Sales Comparison (K Units) by Application (2013-2025)
Figure Global Sales Market Share of Pulmonary Arterial Hypertension Treatment by Application in 2017
Figure Hospital Pharmacies Examples
Table Key Downstream Customer in Hospital Pharmacies
Figure Retail Pharmacies Examples
Table Key Downstream Customer in Retail Pharmacies
Figure Online Pharmacies Examples
Table Key Downstream Customer in Online Pharmacies
Figure Global Pulmonary Arterial Hypertension Treatment Market Size (Million USD) by Regions (2013-2025)
Figure United States Pulmonary Arterial Hypertension Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Pulmonary Arterial Hypertension Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Pulmonary Arterial Hypertension Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Pulmonary Arterial Hypertension Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Pulmonary Arterial Hypertension Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Pulmonary Arterial Hypertension Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Pulmonary Arterial Hypertension Treatment Sales Volume (K Units) and Growth Rate (2013-2025)
Figure Global Pulmonary Arterial Hypertension Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Pulmonary Arterial Hypertension Treatment Sales Volume (K Units) (2013-2018)
Table Global Pulmonary Arterial Hypertension Treatment Sales (K Units) of Key Players/Suppliers (2013-2018)
Table Global Pulmonary Arterial Hypertension Treatment Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Pulmonary Arterial Hypertension Treatment Sales Share by Players/Suppliers
Figure 2017 Pulmonary Arterial Hypertension Treatment Sales Share by Players/Suppliers
Figure Global Pulmonary Arterial Hypertension Treatment Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Pulmonary Arterial Hypertension Treatment Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Pulmonary Arterial Hypertension Treatment Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Pulmonary Arterial Hypertension Treatment Revenue Share by Players
Table 2017 Global Pulmonary Arterial Hypertension Treatment Revenue Share by Players
Table Global Pulmonary Arterial Hypertension Treatment Sales (K Units) and Market Share by Type (2013-2018)
Table Global Pulmonary Arterial Hypertension Treatment Sales Share (K Units) by Type (2013-2018)
Figure Sales Market Share of Pulmonary Arterial Hypertension Treatment by Type (2013-2018)
Figure Global Pulmonary Arterial Hypertension Treatment Sales Growth Rate by Type (2013-2018)
Table Global Pulmonary Arterial Hypertension Treatment Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Pulmonary Arterial Hypertension Treatment Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Pulmonary Arterial Hypertension Treatment by Type (2013-2018)
Figure Global Pulmonary Arterial Hypertension Treatment Revenue Growth Rate by Type (2013-2018)
Table Global Pulmonary Arterial Hypertension Treatment Sales Volume (K Units) and Market Share by Region (2013-2018)
Table Global Pulmonary Arterial Hypertension Treatment Sales Share by Region (2013-2018)
Figure Sales Market Share of Pulmonary Arterial Hypertension Treatment by Region (2013-2018)
Figure Global Pulmonary Arterial Hypertension Treatment Sales Growth Rate by Region in 2017
Table Global Pulmonary Arterial Hypertension Treatment Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Pulmonary Arterial Hypertension Treatment Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Pulmonary Arterial Hypertension Treatment by Region (2013-2018)
Figure Global Pulmonary Arterial Hypertension Treatment Revenue Growth Rate by Region in 2017
Table Global Pulmonary Arterial Hypertension Treatment Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Pulmonary Arterial Hypertension Treatment Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Pulmonary Arterial Hypertension Treatment by Region (2013-2018)
Figure Global Pulmonary Arterial Hypertension Treatment Revenue Market Share by Region in 2017
Table Global Pulmonary Arterial Hypertension Treatment Sales Volume (K Units) and Market Share by Application (2013-2018)
Table Global Pulmonary Arterial Hypertension Treatment Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Pulmonary Arterial Hypertension Treatment by Application (2013-2018)
Figure Global Pulmonary Arterial Hypertension Treatment Sales Market Share by Application (2013-2018)
Figure United States Pulmonary Arterial Hypertension Treatment Sales (K Units) and Growth Rate (2013-2018)
Figure United States Pulmonary Arterial Hypertension Treatment Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Pulmonary Arterial Hypertension Treatment Sales Price (USD/Unit) Trend (2013-2018)
Table United States Pulmonary Arterial Hypertension Treatment Sales Volume (K Units) by Players (2013-2018)
Table United States Pulmonary Arterial Hypertension Treatment Sales Volume Market Share by Players (2013-2018)
Figure United States Pulmonary Arterial Hypertension Treatment Sales Volume Market Share by Players in 2017
Table United States Pulmonary Arterial Hypertension Treatment Sales Volume (K Units) by Type (2013-2018)
Table United States Pulmonary Arterial Hypertension Treatment Sales Volume Market Share by Type (2013-2018)
Figure United States Pulmonary Arterial Hypertension Treatment Sales Volume Market Share by Type in 2017
Table United States Pulmonary Arterial Hypertension Treatment Sales Volume (K Units) by Application (2013-2018)
Table United States Pulmonary Arterial Hypertension Treatment Sales Volume Market Share by Application (2013-2018)
Figure United States Pulmonary Arterial Hypertension Treatment Sales Volume Market Share by Application in 2017
Figure Europe Pulmonary Arterial Hypertension Treatment Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Pulmonary Arterial Hypertension Treatment Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Pulmonary Arterial Hypertension Treatment Sales Price (USD/Unit) Trend (2013-2018)
Table Europe Pulmonary Arterial Hypertension Treatment Sales Volume (K Units) by Players (2013-2018)
Table Europe Pulmonary Arterial Hypertension Treatment Sales Volume Market Share by Players (2013-2018)
Figure Europe Pulmonary Arterial Hypertension Treatment Sales Volume Market Share by Players in 2017
Table Europe Pulmonary Arterial Hypertension Treatment Sales Volume (K Units) by Type (2013-2018)
Table Europe Pulmonary Arterial Hypertension Treatment Sales Volume Market Share by Type (2013-2018)
Figure Europe Pulmonary Arterial Hypertension Treatment Sales Volume Market Share by Type in 2017
Table Europe Pulmonary Arterial Hypertension Treatment Sales Volume (K Units) by Application (2013-2018)
Table Europe Pulmonary Arterial Hypertension Treatment Sales Volume Market Share by Application (2013-2018)
Figure Europe Pulmonary Arterial Hypertension Treatment Sales Volume Market Share by Application in 2017
Figure China Pulmonary Arterial Hypertension Treatment Sales (K Units) and Growth Rate (2013-2018)
Figure China Pulmonary Arterial Hypertension Treatment Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Pulmonary Arterial Hypertension Treatment Sales Price (USD/Unit) Trend (2013-2018)
Table China Pulmonary Arterial Hypertension Treatment Sales Volume (K Units) by Players (2013-2018)
Table China Pulmonary Arterial Hypertension Treatment Sales Volume Market Share by Players (2013-2018)
Figure China Pulmonary Arterial Hypertension Treatment Sales Volume Market Share by Players in 2017
Table China Pulmonary Arterial Hypertension Treatment Sales Volume (K Units) by Type (2013-2018)
Table China Pulmonary Arterial Hypertension Treatment Sales Volume Market Share by Type (2013-2018)
Figure China Pulmonary Arterial Hypertension Treatment Sales Volume Market Share by Type in 2017
Table China Pulmonary Arterial Hypertension Treatment Sales Volume (K Units) by Application (2013-2018)
Table China Pulmonary Arterial Hypertension Treatment Sales Volume Market Share by Application (2013-2018)
Figure China Pulmonary Arterial Hypertension Treatment Sales Volume Market Share by Application in 2017
Figure Japan Pulmonary Arterial Hypertension Treatment Sales (K Units) and Growth Rate (2013-2018)
Figure Japan Pulmonary Arterial Hypertension Treatment Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Pulmonary Arterial Hypertension Treatment Sales Price (USD/Unit) Trend (2013-2018)
Table Japan Pulmonary Arterial Hypertension Treatment Sales Volume (K Units) by Players (2013-2018)
Table Japan Pulmonary Arterial Hypertension Treatment Sales Volume Market Share by Players (2013-2018)
Figure Japan Pulmonary Arterial Hypertension Treatment Sales Volume Market Share by Players in 2017
Table Japan Pulmonary Arterial Hypertension Treatment Sales Volume (K Units) by Type (2013-2018)
Table Japan Pulmonary Arterial Hypertension Treatment Sales Volume Market Share by Type (2013-2018)
Figure Japan Pulmonary Arterial Hypertension Treatment Sales Volume Market Share by Type in 2017
Table Japan Pulmonary Arterial Hypertension Treatment Sales Volume (K Units) by Application (2013-2018)
Table Japan Pulmonary Arterial Hypertension Treatment Sales Volume Market Share by Application (2013-2018)
Figure Japan Pulmonary Arterial Hypertension Treatment Sales Volume Market Share by Application in 2017
Figure Southeast Asia Pulmonary Arterial Hypertension Treatment Sales (K Units) and Growth Rate (2013-2018)
Figure Southeast Asia Pulmonary Arterial Hypertension Treatment Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Pulmonary Arterial Hypertension Treatment Sales Price (USD/Unit) Trend (2013-2018)
Table Southeast Asia Pulmonary Arterial Hypertension Treatment Sales Volume (K Units) by Players (2013-2018)
Table Southeast Asia Pulmonary Arterial Hypertension Treatment Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Pulmonary Arterial Hypertension Treatment Sales Volume Market Share by Players in 2017
Table Southeast Asia Pulmonary Arterial Hypertension Treatment Sales Volume (K Units) by Type (2013-2018)
Table Southeast Asia Pulmonary Arterial Hypertension Treatment Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Pulmonary Arterial Hypertension Treatment Sales Volume Market Share by Type in 2017
Table Southeast Asia Pulmonary Arterial Hypertension Treatment Sales Volume (K Units) by Application (2013-2018)
Table Southeast Asia Pulmonary Arterial Hypertension Treatment Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Pulmonary Arterial Hypertension Treatment Sales Volume Market Share by Application in 2017
Figure India Pulmonary Arterial Hypertension Treatment Sales (K Units) and Growth Rate (2013-2018)
Figure India Pulmonary Arterial Hypertension Treatment Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Pulmonary Arterial Hypertension Treatment Sales Price (USD/Unit) Trend (2013-2018)
Table India Pulmonary Arterial Hypertension Treatment Sales Volume (K Units) by Players (2013-2018)
Table India Pulmonary Arterial Hypertension Treatment Sales Volume Market Share by Players (2013-2018)
Figure India Pulmonary Arterial Hypertension Treatment Sales Volume Market Share by Players in 2017
Table India Pulmonary Arterial Hypertension Treatment Sales Volume (K Units) by Type (2013-2018)
Table India Pulmonary Arterial Hypertension Treatment Sales Volume Market Share by Type (2013-2018)
Figure India Pulmonary Arterial Hypertension Treatment Sales Volume Market Share by Type in 2017
Table India Pulmonary Arterial Hypertension Treatment Sales Volume (K Units) by Application (2013-2018)
Table India Pulmonary Arterial Hypertension Treatment Sales Volume Market Share by Application (2013-2018)
Figure India Pulmonary Arterial Hypertension Treatment Sales Volume Market Share by Application in 2017
Table GlaxoSmithKline plc Basic Information List
Table GlaxoSmithKline plc Pulmonary Arterial Hypertension Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GlaxoSmithKline plc Pulmonary Arterial Hypertension Treatment Sales Growth Rate (2013-2018)
Figure GlaxoSmithKline plc Pulmonary Arterial Hypertension Treatment Sales Global Market Share (2013-2018)
Figure GlaxoSmithKline plc Pulmonary Arterial Hypertension Treatment Revenue Global Market Share (2013-2018)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Pulmonary Arterial Hypertension Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Eli Lilly and Company Pulmonary Arterial Hypertension Treatment Sales Growth Rate (2013-2018)
Figure Eli Lilly and Company Pulmonary Arterial Hypertension Treatment Sales Global Market Share (2013-2018)
Figure Eli Lilly and Company Pulmonary Arterial Hypertension Treatment Revenue Global Market Share (2013-2018)
Table Pfizer Inc.Actelion Inc Basic Information List
Table Pfizer Inc.Actelion Inc Pulmonary Arterial Hypertension Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Inc.Actelion Inc Pulmonary Arterial Hypertension Treatment Sales Growth Rate (2013-2018)
Figure Pfizer Inc.Actelion Inc Pulmonary Arterial Hypertension Treatment Sales Global Market Share (2013-2018
Figure Pfizer Inc.Actelion Inc Pulmonary Arterial Hypertension Treatment Revenue Global Market Share (2013-2018)
Table United Therapeutic Corporation Basic Information List
Table United Therapeutic Corporation Pulmonary Arterial Hypertension Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure United Therapeutic Corporation Pulmonary Arterial Hypertension Treatment Sales Growth Rate (2013-2018)
Figure United Therapeutic Corporation Pulmonary Arterial Hypertension Treatment Sales Global Market Share (2013-2018)
Figure United Therapeutic Corporation Pulmonary Arterial Hypertension Treatment Revenue Global Market Share (2013-2018)
Table SteadyMed Ltd Basic Information List
Table SteadyMed Ltd Pulmonary Arterial Hypertension Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure SteadyMed Ltd Pulmonary Arterial Hypertension Treatment Sales Growth Rate (2013-2018)
Figure SteadyMed Ltd Pulmonary Arterial Hypertension Treatment Sales Global Market Share (2013-2018)
Figure SteadyMed Ltd Pulmonary Arterial Hypertension Treatment Revenue Global Market Share (2013-2018)
Table Gilead Sciences, Inc Basic Information List
Table Gilead Sciences, Inc Pulmonary Arterial Hypertension Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Gilead Sciences, Inc Pulmonary Arterial Hypertension Treatment Sales Growth Rate (2013-2018)
Figure Gilead Sciences, Inc Pulmonary Arterial Hypertension Treatment Sales Global Market Share (2013-2018
Figure Gilead Sciences, Inc Pulmonary Arterial Hypertension Treatment Revenue Global Market Share (2013-2018)
Table Teva Pharmaceuticals Inc Basic Information List
Table Teva Pharmaceuticals Inc Pulmonary Arterial Hypertension Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Teva Pharmaceuticals Inc Pulmonary Arterial Hypertension Treatment Sales Growth Rate (2013-2018)
Figure Teva Pharmaceuticals Inc Pulmonary Arterial Hypertension Treatment Sales Global Market Share (2013-2018)
Figure Teva Pharmaceuticals Inc Pulmonary Arterial Hypertension Treatment Revenue Global Market Share (2013-2018)
Table Bayer AG Basic Information List
Table Bayer AG Pulmonary Arterial Hypertension Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bayer AG Pulmonary Arterial Hypertension Treatment Sales Growth Rate (2013-2018)
Figure Bayer AG Pulmonary Arterial Hypertension Treatment Sales Global Market Share (2013-2018
Figure Bayer AG Pulmonary Arterial Hypertension Treatment Revenue Global Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pulmonary Arterial Hypertension Treatment
Figure Manufacturing Process Analysis of Pulmonary Arterial Hypertension Treatment
Figure Pulmonary Arterial Hypertension Treatment Industrial Chain Analysis
Table Raw Materials Sources of Pulmonary Arterial Hypertension Treatment Major Players in 2017
Table Major Buyers of Pulmonary Arterial Hypertension Treatment
Table Distributors/Traders List
Figure Global Pulmonary Arterial Hypertension Treatment Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Pulmonary Arterial Hypertension Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Pulmonary Arterial Hypertension Treatment Price (USD/Unit) and Trend Forecast (2018-2025)
Table Global Pulmonary Arterial Hypertension Treatment Sales Volume (K Units) Forecast by Regions (2018-2025)
Figure Global Pulmonary Arterial Hypertension Treatment Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Pulmonary Arterial Hypertension Treatment Sales Volume Market Share Forecast by Regions in 2025
Table Global Pulmonary Arterial Hypertension Treatment Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Pulmonary Arterial Hypertension Treatment Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Pulmonary Arterial Hypertension Treatment Revenue Market Share Forecast by Regions in 2025
Figure United States Pulmonary Arterial Hypertension Treatment Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Pulmonary Arterial Hypertension Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Pulmonary Arterial Hypertension Treatment Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Pulmonary Arterial Hypertension Treatment Revenue and Growth Rate Forecast (2018-2025)
Figure China Pulmonary Arterial Hypertension Treatment Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure China Pulmonary Arterial Hypertension Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Pulmonary Arterial Hypertension Treatment Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Pulmonary Arterial Hypertension Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Pulmonary Arterial Hypertension Treatment Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Pulmonary Arterial Hypertension Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Pulmonary Arterial Hypertension Treatment Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure India Pulmonary Arterial Hypertension Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Pulmonary Arterial Hypertension Treatment Sales (K Units) Forecast by Type (2018-2025)
Figure Global Pulmonary Arterial Hypertension Treatment Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Pulmonary Arterial Hypertension Treatment Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Pulmonary Arterial Hypertension Treatment Revenue Market Share Forecast by Type (2018-2025)
Table Global Pulmonary Arterial Hypertension Treatment Price (USD/Unit) Forecast by Type (2018-2025)
Table Global Pulmonary Arterial Hypertension Treatment Sales (K Units) Forecast by Application (2018-2025)
Figure Global Pulmonary Arterial Hypertension Treatment Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources